Previous close | 65.51 |
Open | 65.23 |
Bid | 65.43 x 20000 |
Ask | 65.44 x 20000 |
Day's range | 65.23 - 65.31 |
52-week range | 60.00 - 74.62 |
Volume | |
Avg. volume | 180 |
Market cap | 82.322B |
Beta (5Y monthly) | 0.51 |
PE ratio (TTM) | 10.76 |
EPS (TTM) | 6.07 |
Earnings date | 01 May 2024 |
Forward dividend & yield | 2.50 (3.81%) |
Ex-dividend date | 19 Apr 2024 |
1y target est | N/A |
The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
In the most recent trading session, CVS Health (CVS) closed at $69.75, indicating a +0.52% shift from the previous trading day.
CVS Health (CVS) closed at $69.39 in the latest trading session, marking a +1.15% move from the prior day.